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Résumé en
anglais
Sex hormone-binding globulin (SHBG) is a plasma glycoprotein that binds with high
affinity to sex steroids, most notably 5α-dihydrotestosterone, testosterone, and 17β-
estradiol, thereby regulating their bioavailability and access to target cells. SHBG
modulates the sex-steroid signaling system by binding to a specific membrane
receptor (SHBG-R). Plasma SHBG levels vary in health and disease due to the effects
of multiple regulation factors (age, body weight, sex steroids, insulin, and others).
SHBG is involved in a number of diseases, including osteoporosis. Several studies
found an inverse correlation between serum SHBG levels and bone mineral density in
both males and females. SHBG levels may predict a number of macro-architectural
characteristics of cortical bone. Weaker links have been reported between SHBG and
bone turnover markers. Finally, high SHBG levels predict the occurrence of
osteoporotic fractures of the vertebras and peripheral bones, most notably the
proximal femur. Together with estradiol, SHBG plays a key role in the genesis of bone
loss and osteoporotic fractures. Given that serum SHBG elevation is associated with
the occurrence of multiple fractures, determination of the serum SHBG level, which
can be readily performed in everyday clinical practice, may constitute a useful new
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